XML 68 R53.htm IDEA: XBRL DOCUMENT v3.24.0.1
Long-Term Investments (Details) - Schedule of Statement of Operation - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
BioFirst [Member]    
Condensed Income Statements, Captions [Line Items]    
Net sales $ 734 $ 30,162
Gross profit 289 8,239
Net loss (1,194,797) (1,274,539)
Share of losses from investments accounted for using the equity method (221,888)
Rgene [Member]    
Condensed Income Statements, Captions [Line Items]    
Net sales
Gross profit
Net loss (291,522) (1,550,123)
Share of losses from investments accounted for using the equity method